Professional Knowledge Library · First-edition purchase enquiries open

Medical Device Change Control and Evidence Decisions

By Arvind RathoreISO 10993 Biocompatibility Consultant · Founder, MedDev Advisory

Changing a supplier, material, manufacturing process or device design? This handbook helps quality and regulatory teams review the evidence and regulatory questions before implementation. Device-specific decisions still require qualified judgment.

Read the 16-Page Preview Request Purchase

Individual licence from ₹14,900 / $179Applicable tax extra · 12-month Update Assurance optional · no automatic renewal

Real 16-page public preview
Versioned first edition
Buyer-specific licence
SHA-256 integrity checks
Published correction policy

First-edition purchase enquiries are open. Review the real preview, then request the exact written offer for your licence and update option. The request creates no order or payment obligation.

20 chapters · 5 parts Source status: 1 September 2026 MDA-HBK-MD-CHANGE-01

Cover of Medical Device Change Control and Evidence Decisions by Arvind Rathore

165first-edition A4 pages

20decision-led chapters

20original figures

8practical appendices

29controlled source records

What the book helps you do

Control the full decision from approved baseline to monitored implementation

Connect baseline, delta, evidence, authority, implementation and monitoring while keeping quality, scientific and market-route decisions appropriately separate.

Reconstruct the baseline

Identify the approved, evidence-represented and currently marketed states before comparing a proposed change.

Decompose the change

Separate atomic, concurrent and cumulative deltas so a small current change is not judged in isolation from prior drift.

Map the complete impact

Connect supplier, material, process, site, sterilization, packaging, labelling, software, use and evidence domains.

Plan the evidence

Convert uncertainty into verification, validation and specialist questions with explicit provenance and applicability.

Separate the authorities

Keep QMS approval, scientific conclusions, market-route decisions and implementation authorization distinct.

Implement and monitor

Control transfer, inventory, training, traceability, open actions and post-implementation signals without losing the decision history.

Complete contents

A controlled path from change request to monitored implementation

Open each part to inspect every chapter in the complete first edition.

PART IControl the decisionChapters 1–4

One Change Request, Several Different Decisions
Establish the Charter, Owner, Authority, and Implementation Hold
Reconstruct the Approved and Marketed Baseline
Decompose Atomic, Concurrent, and Cumulative Changes

PART IIFind the complete impactChapters 5–8

Trace Material, Supplier, Site, Process, Sterilization, Packaging, Labelling, Software, and Use Changes
Map Device, Patient, User, Contact, and System Deltas
Map the Cross-Functional Impact Domains
Judge Evidence Provenance, Applicability, Equivalence, and Bridging

PART IIIPlan the evidenceChapters 9–13

Convert Uncertainty into Answerable Decision Questions
Integrate Risk Management and Benefit–Risk Reasoning
Build the Verification and Validation Evidence Plan
Select Representative Configurations and Worst Cases
Handle Gaps, Adverse Evidence, Interactions, and Cumulative Change

PART IVSeparate the market routesChapters 14–17

Separate QMS Approval, Scientific Conclusion, Regulatory Route, and Implementation Authorization
FDA: 510(k), PMA, IDE, Corrections/Removals, and PCCP Status
EU MDR: Current Devices, Notified-Body Change Control, and Article 120 Legacy Devices
CDSCO: Major/Minor Post-Approval Changes and Current Portal Controls

PART VDecide, implement and learnChapters 18–20

Write a Defensible Decision Memo with Conditions and Open Actions
Control Transfer, Inventory, Labelling, Training, Suppliers, and Traceability
Monitor Post-Implementation Signals, CAPA, PMS, Rollback, and Audit Reconstruction

Actual pages, not mock-ups

Inspect the reasoning, figures and market separation

These are direct renders from the complete first edition. The searchable 16-page preview shows selected, non-consecutive pages before you request a written offer.

Contents page for Medical Device Change Control and Evidence Decisions — **Complete contents:** Inspect all five parts, 20 chapters and eight appendices before requesting an offer.

Preview page showing five controlled change dispositions — **Decision separation:** QMS, scientific, market-route, implementation and post-implementation conclusions remain distinct.

Preview page showing a question-led verification and validation plan — **Evidence planning:** The represented state, method, acceptance basis, deviations and authorized conclusion stay connected.

Preview page explaining maintenance and source control — **Maintenance discipline:** Event monitoring, scheduled reassessment and transparent correction remain part of the publication method.

Open the 16-Page Preview

Buyer-specific licensed package

Know what the written offer will identify

Every licensed package is generated for the named buyer and exact accepted tier. The written offer will identify the exact licensed files, version, price, update option, terms and controlled-delivery method before payment.

Searchable tagged PDF

The complete 165-page reading edition with structured navigation, descriptive links and searchable text.

Editable DOCX, where licensed

Included only with an accepted Organisation or Consultant Practice licence; never included automatically with every tier.

Controlled source register

Twenty-nine dated source records separating legal anchors, regulator material, guidance status and critical limitations.

README and release notes

Practical orientation, exact edition identity, professional-use boundaries, update treatment and correction policy.

Buyer licence certificate

Names the holder, authorised scope, tier, update entitlement, order identity and exact master-file hashes.

Manifest and checksums

Buyer-specific file inventory plus SHA-256 checksums for integrity and document-control verification.

Clear commercial boundary: Online checkout, payment, customer download, and automatic delivery are not currently enabled. Submit a purchase request to receive the exact written offer before you decide whether to pay.

Transparent licence pricing

Choose the licence that matches how the handbook will be used

INR applies in India; USD is for eligible international requests and is confirmed in the written offer. Applicable tax is extra. Update Assurance covers eligible updates for 12 months and never renews automatically.

Individual

₹14,900 / $179

Current edition for your own professional work.

₹19,900 / $239 with 12-month updates

Organisation

₹44,900 / $549

Licensed internal use for the named organisation.

₹59,900 / $749 with 12-month updates

Consultant practice

₹74,900 / $899

Professional-use scope for the named consulting practice.

₹99,900 / $1,199 with 12-month updates

Request This Handbook Offer Compare the core three-book library

Cross-functional by design

Broader than material-change biocompatibility

Biological safety remains one specialist interface. The book connects affected domains without allowing one discipline to approve another’s conclusion.

Longitudinal device-family case

A fictional six-configuration fluid-path family carries supplier, material, extrusion-site, process, sterilization, label-transition and evidence-representation issues across the full book.

Packaging and shelf life

A supporting case separates packaging construction, validation representation, converter evidence and release conditions.

Software, usability and site transfer

Concise cases show when specialized software, human-factors, cybersecurity, process and operations competence must enter the review.

Field correction boundary

A supporting case keeps planned change, correction/removal, containment, regulatory reporting and post-market evidence from collapsing into one workflow.

Buyer fit

Built for the leader coordinating the whole decision

This handbook is likely a good fit if you…

Lead quality or regulatory change decisions at a finished-device manufacturer.
Coordinate supplier, design, manufacturing, sterilization, packaging, labelling, software or intended-use changes.
Need cumulative-change, evidence-bridge, V&V and multi-market reasoning in one system.
Want stronger cross-functional challenge questions and an audit-reconstructable decision path.

It is not the right resource if you expect…

A universal significant-change, filing or implementation answer.
A replacement for an ISO 13485 change-control procedure or controlled QMS records.
One discipline to decide software, cybersecurity, packaging, sterilization, clinical or toxicology questions.
A guarantee of FDA, notified-body or CDSCO acceptance.

One decision ecosystem

Book, operational system, biological extension and expert review

Each layer adds a different kind of value instead of repeating the same forms and prose.

The handbook

Teaches cross-functional judgment, cases, failure modes and the baseline-to-monitoring reasoning chain.

Operational control system

Controls records, owners, holds, evidence, conditions, authorization states and audit reconstruction after authentic buyer-task testing.

Biological-safety extension

Applies the existing material-change biocompatibility workflow to one affected specialist domain.

Expert review

Assesses the defined real change, evidence set, jurisdiction and scope using suitable competent specialists.

Why this edition matters now

Change decisions now span different quality and market-control systems

The book organizes one evidence package without manufacturing a universal global answer. Each jurisdiction retains its own legal anchor, guidance status, route question and authorized decision.

United States

The FDA QMSR, 510(k), PMA, IDE, corrections/removals and current PCCP context remain separate decision lenses.

European Union

Regulation (EU) 2017/745 remains the legal anchor, with notified-body change controls and Article 120 legacy-device considerations handled in their proper context.

India

The CDSCO Medical Devices Rules index, final amendments and current portal controls are used with the actual product, licence and change facts.

About the author

Arvind Rathore

Arvind Rathore is the founder of MedDev Advisory and works with medical-device teams on biological-evaluation, regulatory and evidence decisions that intersect with supplier, material, manufacturing, sterilization, packaging and market-specific change control.

Before establishing the practice, he was a Marie Skłodowska-Curie Early Stage Researcher at INSERM U1026 Biotis within the ImplantSens network. His work covered implantable electrochemical biosensors, cytotoxicity, oxidative stress, sterilization effects and biomaterial–cell interactions, with research placements in France, Germany and Sweden.

He holds an MTech in Biological Sciences and Bioengineering from IIT Kanpur and has peer-reviewed publications in Bioelectrochemistry, Advanced Sensor Research and Biochimie. His research experience informs the handbook; it does not replace device-specific assessment or specialist review.

Full professional profile Credentials and trust controls

Questions before purchase

Handbook FAQ

Is this only a material-change biocompatibility book?

No. The handbook is cross-functional. It covers supplier, design, manufacturing, site, sterilization, packaging, labelling, software, use and other changes while preserving specialist boundaries.

Will the handbook decide whether an FDA submission is required?

No. It helps teams organize the baseline, change, evidence and separate route questions. It does not make a device-specific FDA, EU MDR or CDSCO regulatory decision.

Does it replace an ISO 13485 change-control procedure?

No. It teaches decision reasoning and evidence structure. A manufacturer still needs its controlled quality-system procedures, records, authorities and applicable standards.

How is this different from the free change-control triage tool?

The free tool performs an initial biological-impact screen. The book teaches the broader cross-functional reasoning from baseline reconstruction through implementation monitoring.

How can I request purchase?

First-edition purchase enquiries are open. Submit the offer-request form with your intended licence and update option. MedDev Advisory will send the exact written offer, price, terms and controlled-delivery method for review before any payment.

What is included in the licensed package?

Every buyer-specific licensed package includes the searchable PDF, controlled source register, release notes, README, licence certificate, package manifest and SHA-256 checksums. The editable DOCX is included only where the accepted Organisation or Consultant Practice licence expressly allows it.

Related expert guide

Medical-Device Change-Control Regulatory Impact Assessment

Separate the controlled internal change decision from the market-specific FDA, EU MDR and CDSCO route questions that follow.

Read: Medical-Device Change-Control Regulatory Impact Assessment

First-edition purchase enquiries open

Read the real preview, then request the exact written offer.

Judge the reasoning, figures, cross-functional boundaries and market separation before deciding whether this handbook belongs in your professional library. Your request creates no order or payment obligation.